The rising cases of diabetes in patients will create new growth opportunities for the Global Diabetes Monitoring Devices Market, says Fortune Business Insights in a report, “Diabetes Monitoring Devices Market Size, Share and Industry Analysis by Product (Blood Glucose Meters, Test Strips, Lancets), Distribution Channel (Institutional Sales, Retail Sales) & Regional Forecast, 2019 – 2026.” The global diabetes monitoring devices market was valued at USD 21,614.7 Million in 2018, is expected to reach USD 32,881.9 Million by 2026, exhibiting a CAGR of 5.4%.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetes-monitoring-devices-market-100529
Detailed Table of Content:
- Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Prevalence Of Diabetes By Key Countries
4.2 Pricing Analysis, By Key Regions
4.3 Technological Advancements
4.4 Recent Industry Developments, Mergers & Acquisitions
Continued…
Related Press Release:
Connected Drug Delivery Devices Market
Blood Pressure Monitors Market
Hyaluronic Acid Based Dermal Fillers Market
Diabetes Monitoring Devices Market
Key Industry Developments
- In May 2019, Lifespan Inc., had an exclusive agreement with Sanvita Medical, LLC., a subsidiary of Nova Biomedical Corporation to market continuous glucose monitoring (CGM) sensors. This collaboration has planned the launch CGM systems in North America and select countries in Europe.
- In July 2016, ACON Laboratories, Inc., launched New On Call pro blood glucose meter for multi-patient use. This launch in the US has made the blood glucose testing in the hospitals easier.
- In March 2016, ACON Laboratories, Inc., launched OptiLance push-button safety lancets. The precision molded needles placed in OptiLance and quality springs prevent any needle chatter confirming optimum comfort for the patient.